How should pre‑exposure rabies prophylaxis be administered to high‑risk individuals, including the vaccination schedule and special considerations?

Rabies Pre-Exposure Prophylaxis

Primary Vaccination Schedule

Administer three 1.0-mL intramuscular injections of HDCV or PCECV in the deltoid area on days 0,7, and 21 or 28 for all high-risk individuals requiring pre-exposure prophylaxis. 1

Who Should Receive Pre-Exposure Prophylaxis

Pre-exposure vaccination should be offered to specific high-risk groups 1:

• Veterinarians and their staff - continuous or frequent animal contact 1
• Animal handlers and animal-control officers - particularly in areas where animal rabies is enzootic 1
• Rabies researchers and laboratory workers - those working with rabies virus in research or vaccine production facilities 1
• Cavers - due to potential bat exposure 1
• Persons who frequently handle bats - regardless of location, due to lyssavirus presence on all continents except Antarctica 1
• International travelers - those likely to contact animals in areas where dog rabies is enzootic AND where immediate access to appropriate medical care (including vaccine and immune globulin) is limited 1

Routine pre-exposure prophylaxis for the general U.S. population or routine travelers to areas where rabies is not enzootic is NOT recommended. 1

Rationale for Pre-Exposure Prophylaxis

Pre-exposure vaccination provides three critical benefits 1:

1. Simplifies post-exposure management - eliminates the need for rabies immunoglobulin (RIG) and reduces vaccine doses from 5 to 2 doses 1
2. Provides partial immunity - offers protection if post-exposure prophylaxis is delayed 1
3. Protects against unrecognized exposures - particularly important for bat exposures that may go unnoticed 1

Booster Dose Recommendations Based on Risk Category

Continuous Risk Category (Highest Risk)

Laboratory workers handling rabies virus in research or vaccine production facilities: 1

• Serologic testing every 6 months 1
• Administer IM booster dose if titer falls below complete neutralization at 1:5 serum dilution by RFFIT 1

Frequent Risk Category

Includes rabies diagnostic laboratory workers, cavers, veterinarians and staff, animal-control and wildlife officers in enzootic areas, and persons who frequently handle bats: 1

• Serologic testing every 2 years 1
• Administer single booster dose if titer is less than complete neutralization at 1:5 serum dilution by RFFIT 1

Infrequent Exposure Group

Veterinarians, veterinary students, and animal-control officers in areas where rabies is uncommon to rare, plus certain at-risk international travelers: 1

• No routine serologic testing required 1
• No routine booster doses needed after completing the full primary series 1
• If exposed, these individuals require only 2 doses of vaccine (days 0 and 3) without RIG 1

Updated 2022 Recommendations

More recent ACIP guidance has modified the pre-exposure prophylaxis approach 2:

• Redefined risk categories with more flexible options 2
• Fewer vaccine doses in primary vaccination schedules 2
• Less frequent antibody titer checks for some risk groups 2
• New minimum rabies antibody titer of 0.5 IU/mL (previously complete neutralization at 1:5 dilution) 2

Administration Details and Critical Pitfalls

Proper Injection Site

Always administer in the deltoid area for adults - the gluteal area should NEVER be used as it results in lower neutralizing antibody titers 1. For infants and small children, the anterolateral thigh is acceptable 1.

Vaccine Products Available

Two rabies vaccines are available in the United States 1:

• HDCV (Human Diploid Cell Vaccine)
• PCECV (Purified Chick Embryo Cell Vaccine)

Both are equally immunogenic and safe 1, 3.

Important Clinical Considerations

Intradermal preparations are no longer available in the United States - all pre-exposure prophylaxis must be administered intramuscularly 1. However, international data suggests intradermal regimens can be effective and cost-saving in resource-limited settings 4.

Co-administration with other vaccines is safe - pre-exposure rabies prophylaxis can be given concomitantly with Japanese encephalitis vaccine and routine childhood vaccinations without compromising immunogenicity 5, 6.

Post-Exposure Management for Previously Vaccinated Persons

If a previously vaccinated person is exposed to rabies 1:

• Administer 2 IM doses of vaccine (1.0 mL each in deltoid) on days 0 and 3 1
• Do NOT administer RIG - passive antibody may inhibit the anamnestic response 1
• Local wound care remains critical even for previously vaccinated persons 1

Special Populations

Immunosuppressed patients should postpone pre-exposure vaccination when possible and avoid high-risk activities 1. If vaccination is necessary, post-vaccination serologic testing should be performed to document adequate response 1.

Long-term immunity: Studies demonstrate that adequate antibody levels can persist for up to 10 years in many individuals, with approximately 60% maintaining protective titers without boosters 6. However, individual variation exists, and risk-based monitoring remains important 6.

Clinical Pearls

• Pre-exposure prophylaxis does NOT eliminate the need for post-exposure evaluation and treatment 1
• The primary benefit is simplification of post-exposure management, particularly critical in areas where RIG is unavailable 1
• Early consideration of rabies in differential diagnosis is essential, as delayed diagnosis can result in unnecessary healthcare worker exposures 7
• Standard infection control precautions should be maintained consistently when caring for suspected rabies patients 7
• In Europe and other areas where terrestrial rabies has been eliminated, bat exposures remain the primary concern 8